Cite
HARVARD Citation
Witkin, A. et al. (2017). Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment*. Seminars in ophthalmology. pp. 309-315. [Online].